$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Usage and dosage of lung cancer drug serpatinib and introduction to medication for special groups
2025-10-19 11:44:20
Check Details
Usage and dosage reference and detailed explanation of treatment effect of lung cancer drug Pozitinib
2025-10-19 11:44:20
Check Details
Precautions and treatment effects of lung cancer drug evantumumab
2025-10-19 11:44:20
Check Details
A brief introduction to the adverse reactions, treatment and medication reference of the lung cancer drug Mobotinib
2025-10-19 11:44:20
Check Details
Overview of storage methods and precautions for lung cancer drug capmatinib
2025-10-19 11:44:20
Check Details
Can capmatinib effectively treat the disease?
2025-10-19 11:44:20
Check Details
Is Capmatinib available in China? Is it easy to buy?
2025-10-19 11:44:20
Check Details
The correct way to buy Capmatinib?
2025-10-19 11:44:20
Check Details
How to treat adverse reactions caused by Capmatinib?
2025-10-19 11:44:20
Check Details
Capmatinib price list
2025-10-19 11:44:20
Check Details
List of new purchasing methods for Capmatinib
2025-10-19 11:44:20
Check Details
The latest price of Capmatinib in 2024 published on the entire network
2025-10-19 11:44:20
Check Details
1
2
...
10196
10197
10198
10199
10200
10201
10202
...
10210
10211
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Enfortumab Vedotin (Padcev): Nectin-4-Targeted ADC for Advanced Urothelial Carcinoma
2
Urece (Dotinurad): Highly Selective URAT1 Inhibitor for Gout and Hyperuricemia
3
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
4
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
5
Anagrelide (Agrylin): Managing ET-Related Thrombocytosis
6
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
7
Azacitidine Treatment Guide: Indications, Cross-Border Purchase & Safety Tips
8
Odevixibat: Targeting IBAT to Transform Cholestatic Liver Disease Treatment
9
A Precision FGFR Inhibitor for Cholangiocarcinoma
10
A Revolutionary Targeted Therapy for Hematological Malignancies
11
A New Option for Advanced Renal Cell Carcinoma Treatment
12
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description: